5COR : Cencora Q1 Earnings: Revenue And EPS Beat On Strong Push From...
Cencora posted Q1 sales of $81.5 billion, exceeding forecasts, with strong GLP-1 drug sales. Adjusted EPS beat estimates, and ...
CNN16d
Cencora, Inc.
Cencora, Inc. is a pharmaceutical sourcing and ... The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the ...
Business Insider9d
Cencora (COR) Gets a Hold from Wells Fargo
Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report ... distributes a comprehensive offering of brand-name, specialty brand-name & generic Related ...
Business Insider15d
Cencora’s Strong Partnership with Walgreens Supports Buy Rating
The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic Cencora NewsMORE Related Stocks ...